USRE37766EExpiredUtility
K. lactis pyruvate-decarboxylase promoter and use thereof
Est. expiryJul 8, 2012(expired)· nominal 20-yr term from priority
C07K 14/765C12N 9/88C12N 15/815
26
PatentIndex Score
0
Cited by
8
References
12
Claims
Abstract
The present invention concerns DNA sequences comprising all or part of the K. lactis promoter gene PDC1 or a derivative thereof, and having transcriptional promoter activity. The invention also relates to the use of the sequences for the expression of recombinant genes.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A An isolated DNA sequence selected from the group consisting of:
(a) the sequence presented in SEQ ID NO:1 or SEQ ID NO:4;
(b) a complementary strand of the sequence presented in SEQ ID NO:1 or SEQ ID NO:4; and
(c) a fragment of the sequence of (a) or (b); wherein said DNA sequence possesses transcriptional promoter activity.
2. A recombinant DNA comprising a DNA sequence according to claim 1 .
3. A recombinant DNA according to claim 2 , further comprising one or more structural genes.
4. A recombinant DNA according to claim 3 , further comprising signals enabling secretion of expression products of said one or more structural genes.
5. A recombinant DNA according to claim 3 , wherein the one or more structural genes encode proteins of pharmaceutical or food-processing interest.
6. A recombinant DNA according to claim 2 , wherein said recombinant DNA is an autonomous or integrative replication vector.
7. A recombinant cell containing a DNA sequence according to claim 1 .
8. A recombinant cell according to claim 7 , characterized in that said cell is a yeast.
9. A recombinant cell according to claim 8 , characterized in that said cell is a yeast of the genus Kluyveromyces.
10. A process for the production of recombinant proteins, comprising culturing a recombinant cell according to claim 7 and recovering the proteins produced.
11. A process according to claim 10 , wherein said proteins are of pharmaceutical or food-processing interest.
12. A process according to claim 10 , wherein the protein is human serum albumin or a natural variant of human servin albumin resulting from polymorphism.Join the waitlist — get patent alerts
Track USRE37766E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.